April 22, 2024

Nordic Life Sience Days 2025

Nordic Life Sience Days 2025
Go back

Join us for NLSDays 2025, the premier life science event in the Nordics!

Experience two days of groundbreaking insights, networking opportunities, and cutting-edge advancements in the life science industry. Connect with leading experts, industry peers, and potential partners from across the world.

Nordic Life Science Days 2025 will be held, for the first time, in Gothenburg, Sweden on 13-14 October at Svenska Mässan located at Mässans Gata/Korsvägen, 412 94 Göteborg.

We look forward to seeing you there!

BioRN members receive a 15 % discount.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
GalaTek GmbH and a:head bio AG Announce Strategic Collaboration to Automate Human Brain Organoid Workflows

GalaTek GmbH and a:head bio AG Announce Strategic Collaboration to Automate Human Brain Organoid Workflows

Vienna, Austria – October 22, 2025 – GalaTek GmbH, a leading innovator in laboratory automation technologies, and a:head bio AG, a pioneering biotech company specializing in human brain organoid research, today announced a strategic collaboration aimed at advancing the automation of brain organoid workflows. The partnership aims to integrate GalaTek’s advanced robotics and software platforms with […]

read more
Clean Tech Innovation Day & Solar TAP Industry Day: Advanced solutions are needed

Clean Tech Innovation Day & Solar TAP Industry Day: Advanced solutions are needed

Heidelberg, Germany, October 22, 2025 – It’s all about a sustainable, smarter energy future: Clean Tech Innovation Day & Solar TAP Industry Day showed that this can only be achieved with a shared mission and vision. More than 70 participants from science, industry, and start-ups took the opportunity at the Heidelberg Congress Center to exchange […]

read more
Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Paris, October 17, 2025. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Wayrilz (rilzabrutinib) as a new treatment for immune thrombocytopenia (ITP) in adult patients who are refractory to other […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp